Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonothrombolysis in STEMI Patients Receiving Fibrinolysis
NCT04217304Phase 2Terminated
- Sponsor
- University of Alberta
- Start
- Feb 2021
- Primary completion
- Jan 2026
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres in ST elevation myocardial infarction (STEMI), sponsored by University of Alberta. Started Feb 2021; status: terminated.
02
Drugs
perflutren lipid microspheres
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04217304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217304.